drug affinity complex is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-05-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
| Property | Value | Notes |
|---|---|---|
| Molecular weight (no linker) | ~3.37 kDa | Calculated from peptide sequence |
| Molecular weight (with linker) | ~3.65 kDa | Includes albumin-binding moiety |
| Appearance | White to off-white powder | Typically lyophilized |
| Solubility | Soluble in water | Also dissolves in aqueous buffers |
| Common synonyms | Modified GRF(1-29), DAC:GRF | Usage varies by source |
Reported half-lives differ widely between the two variants and between species. Values for the albumin-binding form are usually expressed in days, while the unconjugated form is measured in minutes to a few hours. Sampling schedules, assay sensitivity, and route of administration all influence the numbers, which limits direct comparison across studies. Whether sustained receptor occupancy produces different downstream effects from pulsatile stimulation remains an open question in the published work. Claims about relative potency should therefore be read alongside the specific study design that produced them.
Lyophilised powder is the usual supplied form. The material is hygroscopic, so vials are typically equilibrated to room temperature before opening in order to prevent condensation on the contents. Long-term storage is generally described at minus twenty degrees Celsius or colder, protected from light and moisture. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of soluble material. A reconstituted solution is considerably less stable than the dry powder and is normally kept refrigerated for short periods only.
Identity and purity are assessed mainly by reversed-phase high-performance liquid chromatography combined with mass spectrometry. The chromatographic separation resolves the target peptide from truncation products and from species carrying oxidised residues, while mass measurement confirms the expected molecular mass. Because the two common variants differ by roughly 280 daltons, a mass determination distinguishes them unambiguously. Purity is often quoted as a percentage of total peak area, although that figure depends on the detection wavelength and the integration method applied.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
List of largest empires List of military conflicts spanning multiple wars List of countries by number of military and paramilitary personnel List of militaries by country List of ongoing armed conflicts Interwar period Post–Cold War era
In 1877, Schumacher adopted the Quaker symbol, the first registered trademark for a breakfast cereal. The acceptance of "horse food" for human consumption encouraged other entrepreneurs to enter the industry. Henry Parsons Crowell started operations in 1882, and John Robert Stuart in 1885. Crowell cut costs by consolidating every step of the processing—grading, cleaning, hulling, cutting, rolling, packaging, and shipping—in one factory operating at Ravenna, Ohio. Stuart operated mills in Chicago and Cedar Rapids, Iowa. Stuart and Crowell combined in 1885 and initiated a price war. After a fire at his mill in Akron, Schumacher joined Stuart and Crowell to form the Consolidated Oatmeal Company. The American Cereal Company (Quaker Oats, but see below) created a cereal made from oats in 1877, manufacturing the product in Akron, Ohio. Separately, in 1888, a trust or holding company combined the nation's seven largest mills into the American Cereal Company using the Quaker Oats brand name. By 1900, technology, entrepreneurship, and the "Man in Quaker Garb"—a symbol of plain honesty and reliability—gave Quaker Oats a national market and annual sales of $10 million (equivalent to $390 million today). Early in the 20th century, the Quaker Oats Company (formed in 1901 to replace the American Cereal Company) ventured into the world market. Schumacher, the innovator; Stuart, the manager and financial leader; and Crowell, the creative merchandiser, advertiser, and promoter, doubled sales every decade. Alexander P.
Bourke was on Norris's ward at the same time as Ludlam and Wilby, meaning he had contact with all three at the same time. In each case, the fatal dose of insulin had been administered at night, when Norris worked. At the time of Hall's death, Norris suspiciously said to colleagues: "it is always in the morning when things go wrong" and "someone always dies when I do nights". He also would have known doctors were not on duty overnight at the hospitals, so they couldn't help the patients when they all collapsed during Norris's night shifts. Amongst the things the victims all had in common was that they were all frail women and that they all died after suffering broken hips.
== Reception == Spin wrote, "Poised to become this year's Scorpions, the band (like so many other freeze-dried HM acts) looks more like Spinal Tap. Metal Heart reeks of studied moves. The squalling guitars and lockstep beat on Metal Heart are characteristic Eurometal trademarks. Accept is just another commodity."
Sources: en.wikipedia.org
== Structure and function == CCS is composed of three domains. Domain I is located on the N-terminus and contains the MXCXXC Cu binding sequence. It has been determined to be necessary for function of CCS but its specific role is currently unknown. The structure of domain II greatly resembles that of SOD1 which allows it to perform the function of binding to SOD1. Domain III contains a CXC Cu binding motif and performs the Cu insertion and subsequent disulfide oxidation of SOD1. When CCS docks to SOD1, cysteine 244 of CCS and 57 of SOD1 form a disulfide linkage. This disulfide bond is then transferred to form a disulfide bridge between cysteine 57 and 146 of SOD1. CCS's catalytic oxidation of SOD1's disulfide bridge can only be performed in the presence of oxygen. Furthermore, the disulfide linkage of SOD1 can be performed without the presence of CCS but requires oxygen and is much slower. Additionally, CCS is proposed to help the proper folding of SOD1 by binding in the apo-state. As well as SOD1, CCS (gene) has been shown to interact with APBA1.
Writing for The Guardian, Seumas Milne stated the result of the post–Cold War narrative that Stalin and Hitler were twin evils, therefore communism is as monstrous as Nazism, "has been to relativise the unique crimes of Nazism, bury those of colonialism and feed the idea that any attempt at radical social change will always lead to suffering, killing and failure." Other leftists, including some Marxist–Leninists, apply self-criticism, and have at times criticised Marxist–Leninist praxis and some actions by Marxist–Leninist governments, while acknowledging its advancements, emancipatory acts such as their support of labour rights, women's rights, anti-imperialism, democratic efforts, egalitarian achievements, modernisation, and the creation of mass social programs for education, health, housing, and jobs as well as the increase of living standards.
=== Biomarker of Turner syndrome === Turner syndrome is the most common sex chromosome-related inherited diseases in females around the world, with the incidence of 1 in 2000 live female births. One of the significant pathological features is the premature ovarian failure, leading to amenorrhea or even infertility. Follicle stimulating hormone and inhibin B were recommended to be monitored routinely by specialists to speculate the condition of ovary. Recently, anti-Müllerian hormone is advised as a more accurate biomarker for follicular development by several researchers. The biological function of anti-Müllerian hormone in ovary is to counteract the recruitment of primordial follicles triggered by FSH, reserving the follicle pool for further recruitment and ovulation. When menopause takes place, the serum concentration of anti-Müllerian hormone will be nearly undetectable among normal women. Thus, variations in AMH levels during childhood may theoretically predict the duration of any given girl's reproductive life span, assuming that the speed of the continuous follicle loss is comparable between individuals.
=== Description === Eflornithine is a "suicide inhibitor," irreversibly binding to ornithine decarboxylase (ODC) and preventing the natural substrate ornithine from accessing the active site (Figure 1). Within the active site of ODC, eflornithine undergoes decarboxylation with the aid of cofactor pyridoxal 5'-phosphate (PLP). Because of its additional difluoromethyl group in comparison to ornithine, eflornithine is able to bind to a neighboring Cys-360 residue, permanently remaining fixated within the active site.
=== Stand-up === Hart's first stand-up performance took place at The Laff House in his native Philadelphia under the name of Lil Kev, which did not go well. His career suffered a slow start and he was booed offstage several times, once even having a piece of chicken thrown at him. After those initial unsuccessful shows, he began entering comedy competitions throughout Massachusetts, with audience receptions eventually improving. It took time for Hart to develop a unique comedic style. After an early period of attempting to imitate comedians like Chris Tucker, he found his own rhythm by delving into his insecurities and life experiences. He said: "Because of what I do, it has to be an open book. But right now, this is a book that is being written." Hart's comedy tours began in 2009 with his act titled I'm a Grown Little Man, followed by Seriously Funny in 2010, Laugh at My Pain in 2011, and Let Me Explain in 2013, the last two of which were also released as features in theaters. Hart grossed over $15 million from "Laugh at My Pain", making it one of the year's top-selling comedy tours. Hart also has a game app available through iTunes called "Little Jumpman". His Facebook page, Twitter account, and YouTube channel are all connected to and accessible through this app. Most overseas fans of Hart discovered him on YouTube, as well. On April 9, 2015, Hart embarked on a comedy world tour titled the What Now? Tour at the AT&T Center in San Antonio, which concluded on August 7, 2016, at the Columbus Civic Center in Columbus, Georgia.
Sources: en.wikipedia.org
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.
Early development used the albumin-binding form, and a shorter variant was later discussed under the same label. Because the two differ in half-life and handling, ambiguity arises whenever a source omits the variant designation.
The compound derives from that fragment but is not identical to it. The parent fragment lacks the stabilizing substitutions, so its degradation rate and duration of action differ noticeably.
Chromatography reports how much material elutes as a single peak but does not confirm what that material is. Mass spectrometry supplies the molecular mass, which is characteristic of a given sequence and its modifications. Together the two methods support both a purity figure and an identity claim.